APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunotoxins

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Immunotoxins Industry Growth and Trends Forecast to 2032

22 December 2025106 pages

Choose your research edition.

Industry ResearchImmunotoxins Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunotoxins Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Immunotoxins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunotoxins Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunotoxins Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Immunotoxins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immunotoxins is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immunotoxins is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunotoxins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunotoxins include Bayer HealthCare, Amgen, Research Corporation Technologies, Neurocrine Biosciences, Genmab, Genentech, CuraGen Corporation, Celldex Therapeutics and Biotest, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immunotoxins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immunotoxins market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immunotoxins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immunotoxins.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Immunotoxins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immunotoxins Market by Company

Bayer HealthCare

Amgen

Research Corporation Technologies

Neurocrine Biosciences

Genmab

Genentech

CuraGen Corporation

Celldex Therapeutics

Biotest

AREVA Med

Immunotoxins Segment by Type

Diphtheria Toxin (DT) & DT Derivatives

Ribonucleases based Immunotoxins

Pseudomonas Exotoxin (PE) & PE Derivatives

Anthrax Based Toxins

Ribosome Inactivating Proteins Based Immunotoxins

Others

Immunotoxins Segment by Application

Solid Tumors

Leukemias

Immunotoxins Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunotoxins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunotoxins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunotoxins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunotoxins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Immunotoxins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diphtheria Toxin (DT) & DT Derivatives Table 2. Major Company of Ribonucleases based Immunotoxins Table 3. Major Company of Pseudomonas Exotoxin (PE) & PE Derivatives Table 4. Major Company of Anthrax Based Toxins Table 5. Major Company of Ribosome Inactivating Proteins Based Immunotoxins Table 6. Major Company of Others Table 7. Global Immunotoxins Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Immunotoxins Sales by Type (2021-2026) & (k units) Table 9. Global Immunotoxins Sales Market Share in Volume by Type (2021-2026) Table 10. Global Immunotoxins Sales by Type (2021-2026) & (US$ Million) Table 11. Global Immunotoxins Sales Market Share in Value by Type (2021-2026) Table 12. Global Immunotoxins Price by Type (2021-2026) & (US$/unit) Table 13. Global Immunotoxins Sales by Type (2027-2032) & (k units) Table 14. Global Immunotoxins Sales Market Share in Volume by Type (2027-2032) Table 15. Global Immunotoxins Sales by Type (2027-2032) & (US$ Million) Table 16. Global Immunotoxins Sales Market Share in Value by Type (2027-2032) Table 17. Global Immunotoxins Price by Type (2027-2032) & (US$/unit) Table 18. North America Immunotoxins Sales by Type (2021-2026) & (k units) Table 19. North America Immunotoxins Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Immunotoxins Sales by Type (2021-2026) & (k units) Table 21. Europe Immunotoxins Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Immunotoxins Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Immunotoxins Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Immunotoxins Sales by Type (2021-2026) & (k units) Table 25. Latin America Immunotoxins Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Immunotoxins Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Immunotoxins Sales by Type (2021-2026) & (US$ Million) Table 28. Immunotoxins Industry Trends Table 29. Immunotoxins Industry Drivers Table 30. Immunotoxins Industry Opportunities and Challenges Table 31. Immunotoxins Industry Restraints Table 32. Global Immunotoxins Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Immunotoxins Revenue Market Share by Company (2021-2026) Table 34. Global Immunotoxins Sales by Company (2021-2026) & (k units) Table 35. Global Immunotoxins Sales Share by Company (2021-2026) Table 36. Global Immunotoxins Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Immunotoxins Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Immunotoxins Major Company Production Sites and Headquarters Table 39. Global Immunotoxins Company, Product Type & Application Table 40. Global Immunotoxins Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Immunotoxins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Immunotoxins Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Immunotoxins Sales by Region (2021-2026) & (k units) Table 45. Global Immunotoxins Sales Market Share in Volume by Region (2021-2026) Table 46. Global Immunotoxins Sales by Region (2021-2026) & (US$ Million) Table 47. Global Immunotoxins Sales Market Share in Value by Region (2021-2026) Table 48. Global Immunotoxins Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Immunotoxins Sales by Region (2027-2032) & (k units) Table 50. Global Immunotoxins Sales Market Share in Volume by Region (2027-2032) Table 51. Global Immunotoxins Sales by Region (2027-2032) & (US$ Million) Table 52. Global Immunotoxins Sales Market Share in Value by Region (2027-2032) Table 53. Global Immunotoxins Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Immunotoxins Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Immunotoxins Sales by Application (2021-2026) & (k units) Table 56. Global Immunotoxins Sales Market Share in Volume by Application (2021-2026) Table 57. Global Immunotoxins Sales by Application (2021-2026) & (US$ Million) Table 58. Global Immunotoxins Sales Market Share in Value by Application (2021-2026) Table 59. Global Immunotoxins Price by Application (2021-2026) & (US$/unit) Table 60. Global Immunotoxins Sales by Application (2027-2032) & (k units) Table 61. Global Immunotoxins Sales Market Share in Volume by Application (2027-2032) Table 62. Global Immunotoxins Sales by Application (2027-2032) & (US$ Million) Table 63. Global Immunotoxins Sales Market Share in Value by Application (2027-2032) Table 64. Global Immunotoxins Price by Application (2027-2032) & (US$/unit) Table 65. North America Immunotoxins Sales by Application (2021-2026) & (k units) Table 66. North America Immunotoxins Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Immunotoxins Sales by Application (2021-2026) & (k units) Table 68. Europe Immunotoxins Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Immunotoxins Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Immunotoxins Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Immunotoxins Sales by Application (2021-2026) & (k units) Table 72. Latin America Immunotoxins Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Immunotoxins Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Immunotoxins Sales by Application (2021-2026) & (US$ Million) Table 75. Bayer HealthCare Company Information Table 76. Bayer HealthCare Business Overview Table 77. Bayer HealthCare Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Bayer HealthCare Immunotoxins Product Portfolio Table 79. Bayer HealthCare Recent Development Table 80. Amgen Company Information Table 81. Amgen Business Overview Table 82. Amgen Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Amgen Immunotoxins Product Portfolio Table 84. Amgen Recent Development Table 85. Research Corporation Technologies Company Information Table 86. Research Corporation Technologies Business Overview Table 87. Research Corporation Technologies Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Research Corporation Technologies Immunotoxins Product Portfolio Table 89. Research Corporation Technologies Recent Development Table 90. Neurocrine Biosciences Company Information Table 91. Neurocrine Biosciences Business Overview Table 92. Neurocrine Biosciences Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Neurocrine Biosciences Immunotoxins Product Portfolio Table 94. Neurocrine Biosciences Recent Development Table 95. Genmab Company Information Table 96. Genmab Business Overview Table 97. Genmab Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Genmab Immunotoxins Product Portfolio Table 99. Genmab Recent Development Table 100. Genentech Company Information Table 101. Genentech Business Overview Table 102. Genentech Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Genentech Immunotoxins Product Portfolio Table 104. Genentech Recent Development Table 105. CuraGen Corporation Company Information Table 106. CuraGen Corporation Business Overview Table 107. CuraGen Corporation Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. CuraGen Corporation Immunotoxins Product Portfolio Table 109. CuraGen Corporation Recent Development Table 110. Celldex Therapeutics Company Information Table 111. Celldex Therapeutics Business Overview Table 112. Celldex Therapeutics Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Celldex Therapeutics Immunotoxins Product Portfolio Table 114. Celldex Therapeutics Recent Development Table 115. Biotest Company Information Table 116. Biotest Business Overview Table 117. Biotest Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Biotest Immunotoxins Product Portfolio Table 119. Biotest Recent Development Table 120. AREVA Med Company Information Table 121. AREVA Med Business Overview Table 122. AREVA Med Immunotoxins Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. AREVA Med Immunotoxins Product Portfolio Table 124. AREVA Med Recent Development Table 125. North America Immunotoxins Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 126. North America Immunotoxins Sales by Country (2021-2026) & (k units) Table 127. North America Immunotoxins Sales Market Share by Country (2021-2026) Table 128. North America Immunotoxins Sales Forecast by Country (2027-2032) & (k units) Table 129. North America Immunotoxins Sales Market Share Forecast by Country (2027-2032) Table 130. North America Immunotoxins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. North America Immunotoxins Market Size by Country (2021-2026) & (US$ Million) Table 132. North America Immunotoxins Market Share by Country (2021-2026) Table 133. North America Immunotoxins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. North America Immunotoxins Market Share Forecast by Country (2027-2032) Table 135. Europe Immunotoxins Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 136. Europe Immunotoxins Sales by Country (2021-2026) & (k units) Table 137. Europe Immunotoxins Sales Market Share by Country (2021-2026) Table 138. Europe Immunotoxins Sales Forecast by Country (2027-2032) & (k units) Table 139. Europe Immunotoxins Sales Market Share Forecast by Country (2027-2032) Table 140. Europe Immunotoxins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Europe Immunotoxins Market Size by Country (2021-2026) & (US$ Million) Table 142. Europe Immunotoxins Market Share by Country (2021-2026) Table 143. Europe Immunotoxins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Europe Immunotoxins Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Immunotoxins Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Immunotoxins Sales by Country (2021-2026) & (k units) Table 147. Asia-Pacific Immunotoxins Sales Market Share by Country (2021-2026) Table 148. Asia-Pacific Immunotoxins Sales Forecast by Country (2027-2032) & (k units) Table 149. Asia-Pacific Immunotoxins Sales Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Immunotoxins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Immunotoxins Market Size by Country (2021-2026) & (US$ Million) Table 152. Asia-Pacific Immunotoxins Market Share by Country (2021-2026) Table 153. Asia-Pacific Immunotoxins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Asia-Pacific Immunotoxins Market Share Forecast by Country (2027-2032) Table 155. Latin America Immunotoxins Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 156. Latin America Immunotoxins Sales by Country (2021-2026) & (k units) Table 157. Latin America Immunotoxins Sales Market Share by Country (2021-2026) Table 158. Latin America Immunotoxins Sales Forecast by Country (2027-2032) & (k units) Table 159. Latin America Immunotoxins Sales Market Share Forecast by Country (2027-2032) Table 160. Latin America Immunotoxins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Latin America Immunotoxins Market Size by Country (2021-2026) & (US$ Million) Table 162. Latin America Immunotoxins Market Share by Country (2021-2026) Table 163. Latin America Immunotoxins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Latin America Immunotoxins Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Immunotoxins Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Immunotoxins Sales by Country (2021-2026) & (k units) Table 167. Middle East and Africa Immunotoxins Sales Market Share by Country (2021-2026) Table 168. Middle East and Africa Immunotoxins Sales Forecast by Country (2027-2032) & (k units) Table 169. Middle East and Africa Immunotoxins Sales Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Immunotoxins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Immunotoxins Market Size by Country (2021-2026) & (US$ Million) Table 172. Middle East and Africa Immunotoxins Market Share by Country (2021-2026) Table 173. Middle East and Africa Immunotoxins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Middle East and Africa Immunotoxins Market Share Forecast by Country (2027-2032) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Immunotoxins Distributors List Table 178. Immunotoxins Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Immunotoxins Image Figure 2. Global Immunotoxins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunotoxins Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunotoxins Sales (2021-2032) & (k units) Figure 5. Diphtheria Toxin (DT) & DT Derivatives Image Figure 6. Global Diphtheria Toxin (DT) & DT Derivatives Sales YoY Growth (2021-2032) & (k units) Figure 7. Ribonucleases based Immunotoxins Image Figure 8. Global Ribonucleases based Immunotoxins Sales YoY Growth (2021-2032) & (k units) Figure 9. Pseudomonas Exotoxin (PE) & PE Derivatives Image Figure 10. Global Pseudomonas Exotoxin (PE) & PE Derivatives Sales YoY Growth (2021-2032) & (k units) Figure 11. Anthrax Based Toxins Image Figure 12. Global Anthrax Based Toxins Sales YoY Growth (2021-2032) & (k units) Figure 13. Ribosome Inactivating Proteins Based Immunotoxins Image Figure 14. Global Ribosome Inactivating Proteins Based Immunotoxins Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Immunotoxins Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Immunotoxins Market Share by Type 2025 VS 2032 Figure 19. North America Immunotoxins Sales Market Share in Volume by Type in 2025 Figure 20. North America Immunotoxins Sales Market Share in Value by Type in 2025 Figure 21. Europe Immunotoxins Sales Market Share in Volume by Type in 2025 Figure 22. Europe Immunotoxins Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Immunotoxins Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Immunotoxins Sales Market Share in Value by Type in 2025 Figure 25. Latin America Immunotoxins Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Immunotoxins Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Immunotoxins Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Immunotoxins Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Immunotoxins Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Solid Tumors Image Figure 32. Global Solid Tumors Sales YoY Growth (2021-2032) & (k units) Figure 33. Leukemias Image Figure 34. Global Leukemias Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Immunotoxins Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Immunotoxins Market Share by Application 2025 VS 2032 Figure 37. North America Immunotoxins Sales Market Share in Volume by Application in 2025 Figure 38. North America Immunotoxins Sales Market Share in Value by Application in 2025 Figure 39. Europe Immunotoxins Sales Market Share in Volume by Application in 2025 Figure 40. Europe Immunotoxins Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Immunotoxins Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Immunotoxins Sales Market Share in Value by Application in 2025 Figure 43. Latin America Immunotoxins Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Immunotoxins Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Immunotoxins Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Immunotoxins Sales Market Share in Value by Application in 2025 Figure 47. North America Immunotoxins Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Immunotoxins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Immunotoxins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Immunotoxins Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Immunotoxins Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Immunotoxins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Immunotoxins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Immunotoxins Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Immunotoxins Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Immunotoxins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Immunotoxins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Immunotoxins Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Immunotoxins Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Immunotoxins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Immunotoxins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Immunotoxins Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Immunotoxins Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Immunotoxins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Immunotoxins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Immunotoxins Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Immunotoxins Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Immunotoxins Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Diphtheria Toxin (DT) & DT Derivatives
  • Ribonucleases based Immunotoxins
  • Pseudomonas Exotoxin (PE) & PE Derivatives
  • Anthrax Based Toxins
  • Ribosome Inactivating Proteins Based Immunotoxins
  • Others
Applications
  • Solid Tumors
  • Leukemias
Companies covered
  • Bayer HealthCare
  • Amgen
  • Research Corporation Technologies
  • Neurocrine Biosciences
  • Genmab
  • Genentech
  • CuraGen Corporation
  • Celldex Therapeutics
  • Biotest
  • AREVA Med

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunotoxins Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Immunotoxins Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Immunotoxins Market by Type
  6. 1.3.1 Diphtheria Toxin (DT) & DT Derivatives
  7. 1.3.2 Ribonucleases based Immunotoxins
  8. 1.3.3 Pseudomonas Exotoxin (PE) & PE Derivatives
  9. 1.3.4 Anthrax Based Toxins
  10. 1.3.5 Ribosome Inactivating Proteins Based Immunotoxins
  11. 1.3.6 Others
  12. 1.4 Global Immunotoxins Market Size by Type
  13. 1.4.1 Global Immunotoxins Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Immunotoxins Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Immunotoxins Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Immunotoxins Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Immunotoxins Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Immunotoxins Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Immunotoxins Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Immunotoxins Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Immunotoxins Industry Trends
  2. 2.2 Immunotoxins Industry Drivers
  3. 2.3 Immunotoxins Industry Opportunities and Challenges
  4. 2.4 Immunotoxins Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Immunotoxins Revenue (2021-2026)
  2. 3.2 Global Top Players by Immunotoxins Sales (2021-2026)
  3. 3.3 Global Top Players by Immunotoxins Price (2021-2026)
  4. 3.4 Global Immunotoxins Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunotoxins Major Company Production Sites & Headquarters
  6. 3.6 Global Immunotoxins Company, Product Type & Application
  7. 3.7 Global Immunotoxins Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunotoxins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunotoxins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunotoxins Tier 1, Tier 2, and Tier 3
4 Immunotoxins Regional Status and Outlook
  1. 4.1 Global Immunotoxins Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Immunotoxins Historic Market Size by Region
  3. 4.2.1 Global Immunotoxins Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Immunotoxins Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Immunotoxins Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Immunotoxins Forecasted Market Size by Region
  7. 4.3.1 Global Immunotoxins Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Immunotoxins Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Immunotoxins Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immunotoxins by Application
  1. 5.1 Immunotoxins Market by Application
  2. 5.1.1 Solid Tumors
  3. 5.1.2 Leukemias
  4. 5.2 Global Immunotoxins Market Size by Application
  5. 5.2.1 Global Immunotoxins Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Immunotoxins Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Immunotoxins Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Immunotoxins Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Immunotoxins Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Immunotoxins Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Immunotoxins Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Immunotoxins Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer HealthCare
  2. 6.1.1 Bayer HealthCare Company Information
  3. 6.1.2 Bayer HealthCare Business Overview
  4. 6.1.3 Bayer HealthCare Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer HealthCare Immunotoxins Product Portfolio
  6. 6.1.5 Bayer HealthCare Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Immunotoxins Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 Research Corporation Technologies
  14. 6.3.1 Research Corporation Technologies Company Information
  15. 6.3.2 Research Corporation Technologies Business Overview
  16. 6.3.3 Research Corporation Technologies Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Research Corporation Technologies Immunotoxins Product Portfolio
  18. 6.3.5 Research Corporation Technologies Recent Developments
  19. 6.4 Neurocrine Biosciences
  20. 6.4.1 Neurocrine Biosciences Company Information
  21. 6.4.2 Neurocrine Biosciences Business Overview
  22. 6.4.3 Neurocrine Biosciences Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Neurocrine Biosciences Immunotoxins Product Portfolio
  24. 6.4.5 Neurocrine Biosciences Recent Developments
  25. 6.5 Genmab
  26. 6.5.1 Genmab Company Information
  27. 6.5.2 Genmab Business Overview
  28. 6.5.3 Genmab Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Genmab Immunotoxins Product Portfolio
  30. 6.5.5 Genmab Recent Developments
  31. 6.6 Genentech
  32. 6.6.1 Genentech Company Information
  33. 6.6.2 Genentech Business Overview
  34. 6.6.3 Genentech Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Genentech Immunotoxins Product Portfolio
  36. 6.6.5 Genentech Recent Developments
  37. 6.7 CuraGen Corporation
  38. 6.7.1 CuraGen Corporation Company Information
  39. 6.7.2 CuraGen Corporation Business Overview
  40. 6.7.3 CuraGen Corporation Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CuraGen Corporation Immunotoxins Product Portfolio
  42. 6.7.5 CuraGen Corporation Recent Developments
  43. 6.8 Celldex Therapeutics
  44. 6.8.1 Celldex Therapeutics Company Information
  45. 6.8.2 Celldex Therapeutics Business Overview
  46. 6.8.3 Celldex Therapeutics Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Celldex Therapeutics Immunotoxins Product Portfolio
  48. 6.8.5 Celldex Therapeutics Recent Developments
  49. 6.9 Biotest
  50. 6.9.1 Biotest Company Information
  51. 6.9.2 Biotest Business Overview
  52. 6.9.3 Biotest Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Biotest Immunotoxins Product Portfolio
  54. 6.9.5 Biotest Recent Developments
  55. 6.10 AREVA Med
  56. 6.10.1 AREVA Med Company Information
  57. 6.10.2 AREVA Med Business Overview
  58. 6.10.3 AREVA Med Immunotoxins Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AREVA Med Immunotoxins Product Portfolio
  60. 6.10.5 AREVA Med Recent Developments
7 North America by Country
  1. 7.1 North America Immunotoxins Sales by Country
  2. 7.1.1 North America Immunotoxins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Immunotoxins Sales by Country (2021-2026)
  4. 7.1.3 North America Immunotoxins Sales Forecast by Country (2027-2032)
  5. 7.2 North America Immunotoxins Market Size by Country
  6. 7.2.1 North America Immunotoxins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Immunotoxins Market Size by Country (2021-2026)
  8. 7.2.3 North America Immunotoxins Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Immunotoxins Sales by Country
  2. 8.1.1 Europe Immunotoxins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Immunotoxins Sales by Country (2021-2026)
  4. 8.1.3 Europe Immunotoxins Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Immunotoxins Market Size by Country
  6. 8.2.1 Europe Immunotoxins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Immunotoxins Market Size by Country (2021-2026)
  8. 8.2.3 Europe Immunotoxins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Immunotoxins Sales by Country
  2. 9.1.1 Asia-Pacific Immunotoxins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Immunotoxins Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Immunotoxins Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Immunotoxins Market Size by Country
  6. 9.2.1 Asia-Pacific Immunotoxins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Immunotoxins Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Immunotoxins Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Immunotoxins Sales by Country
  2. 10.1.1 South America Immunotoxins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Immunotoxins Sales by Country (2021-2026)
  4. 10.1.3 South America Immunotoxins Sales Forecast by Country (2027-2032)
  5. 10.2 South America Immunotoxins Market Size by Country
  6. 10.2.1 South America Immunotoxins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Immunotoxins Market Size by Country (2021-2026)
  8. 10.2.3 South America Immunotoxins Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Immunotoxins Sales by Country
  2. 11.1.1 Middle East and Africa Immunotoxins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Immunotoxins Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Immunotoxins Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Immunotoxins Market Size by Country
  6. 11.2.1 Middle East and Africa Immunotoxins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Immunotoxins Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Immunotoxins Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Immunotoxins Value Chain Analysis
  2. 12.1.1 Immunotoxins Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Immunotoxins Production Mode & Process
  7. 12.2 Immunotoxins Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Immunotoxins Distributors
  10. 12.2.3 Immunotoxins Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst